Articles related to Pain Medicine

Weekly semaglutide administration achieved a 13.7% weight reduction while demonstrating significant improvements in knee osteoarthritis pain, potentially offering a new therapeutic approach for this challenging patient population.

The FDA-designated Class II recall affects specific duloxetine lots where exposure may lead to “temporary or medically reversible health consequences or where the probability of serious adverse health consequences is remote.”

Kratom’s active compounds can produce both stimulant and sedative effects, depending on the dose, but its safety profile and efficacy remain poorly understood.

CGRP inhibitors have shown promise in reducing migraine days and improving quality of life, but their wide-ranging effects throughout the body warrant careful consideration and long-term monitoring.

Recent studies show cannabis use before intercourse helped 67% of women with orgasmic dysfunction achieve improved sexual satisfaction, highlighting its potential as a therapeutic option for female sexual health.

CBD gummies offer a convenient administration method with prolonged effects, but their delayed onset presents unique considerations for therapeutic use. Understanding the pharmacokinetics and individual factors affecting CBD absorption is essential for optimizing patient outcomes.